In cancer cells, eIF2B-mediated translational reprogramming protects cancer cells from apoptosis.58,59 LV108 restored the expression of ZAG and eIF2B, reducing the risk of continued development of NAFLD. This evidence concerns the gene EIF2B2 and metabolic dysfunction-associated steatotic liver disease.